United Community Banks Chairman and CEO Lynn Harton said his company remains open to additional deals after announcing plans to acquire a bank in Gainesville, Georgia. United Community Banks in South ...

April 17 (Reuters) - Belgian biopharmaceutical group UCB (UCB.BR), opens new tab said on Friday it ‌will acquire U.S.-based Neurona Therapeutics for up to $1.15 billion in a deal that will strengthen ...

After a recent streak of buyouts by some of Big Pharma's serial acquirers, Belgium's UCB is getting in on the action with a Friday acquisition potentially worth more than $1 billion. Building on its ...

This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Through an acquisition announced Friday, Belgian drug ...

Investors might want to bet on UCB SA (UCBJY), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

G lobal biopharmaceutical giant UCB, Inc. plans to invest $2 billion in Georgia to establish its first U.S. pharmaceutical biologics manufacturing facility. The investment will generate 330 new jobs ...

Belgium-based UCB selected Gwinnett County, Georgia, as the location for its new U.S. biologics manufacturing facility. The campus will use a digital-first approach by leveraging AI, robotics, and ...

The MarketWatch News Department was not involved in the creation of this content. -- New Gwinnett County facility will strengthen UCB's global biologics manufacturing network and support growing ...

Dan Raby, the senior digital producer for CBS News Atlanta, has been covering everything happening around Georgia for more than a decade. Global biopharmaceutical company UCB, Inc. has named Gwinnett ...

FILE - The North American headquarters of Belgian pharmaceutical company UCB is seen, Nov. 10, 2014, in Smyrna, Ga. (Paul Abell/AP Images for UCB, Inc., File) (Paul Abell) ATLANTA – Belgian ...

UCB plans to build a $2 billion manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the first plant in the U.S. for the Belgium-based company and will produce ...

UCB has entered the red-hot T-cell engager (TCE) space by paying $80 million for the rights to a Chinese biotech’s preclinical autoimmune candidate. At the center of the deal is ATG-201, a CD19/CD3 ...